TRANSACTION AGREEMENT by and between MAYNE PHARMA LLC and THERAPEUTICSMD, INC. DATED AS OF DECEMBER 4, 2022Transaction Agreement • December 5th, 2022 • TherapeuticsMD, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledDecember 5th, 2022 Company Industry JurisdictionThis TRANSACTION AGREEMENT (this “Agreement”) is made as of this 4th day of December, 2022, by and between Mayne Pharma LLC, a Delaware limited liability company (“Purchaser”), and TherapeuticsMD, Inc., a corporation formed under the laws of Nevada (“TXMD”). TXMD and Purchaser are each referred to individually as a “Party” and together as the “Parties.”
LICENSE AGREEMENT by and between MAYNE PHARMA LLC and THERAPEUTICSMD, INC. DATED AS OF DECEMBER 4, 2022License Agreement • December 5th, 2022 • TherapeuticsMD, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledDecember 5th, 2022 Company Industry JurisdictionThis LICENSE AGREEMENT (this “Agreement”) is made as of this 4th day of December, 2022, by and between Mayne Pharma LLC, a limited liability company formed under the laws of Delaware and located at 3301 Benson Drive Suite 401, Raleigh NC 27609 (“Mayne”), and TherapeuticsMD, Inc., a corporation formed under the laws of Nevada and located at 951 Yamato Road, Suite 220, Boca Raton, Florida 33431 (“TXMD”). TXMD and Mayne are each referred to individually as a “Party” and together as the “Parties.”